Multiple cycles of 5-FU, however, decreased proliferation of CD8+ T-cells specific for CT26, indicating the potential for 5-FU to attenuate anti-tumor immunity in some instances by inhibiting proliferation of tumor-specific T-cell populations [112]. Here, CD8A is linked to neoplasm.